Telix Pharmaceuticals (TLX) News Today $9.35 -0.20 (-2.12%) As of 03:51 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock TLX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Telix Pharmaceuticals (ASX:TLX) Falls 24% in a Week After FDA Complete Response Letter2 hours ago | finance.yahoo.comFY2026 Earnings Forecast for TLX Issued By William BlairSeptember 2 at 2:02 AM | marketbeat.comResearch Analysts Set Expectations for TLX FY2026 EarningsSeptember 2 at 2:43 AM | americanbankingnews.comTelix Pharmaceuticals (NASDAQ:TLX) Shares Gap Down - Here's WhyAugust 31 at 11:44 AM | marketbeat.comWilliam Blair Has Bearish Estimate for TLX FY2027 EarningsAugust 31 at 6:30 AM | marketbeat.comWedbush Analysts Decrease Earnings Estimates for TLXAugust 31 at 5:38 AM | marketbeat.comWilliam Blair Has Pessimistic View of TLX FY2027 EarningsAugust 31 at 2:54 AM | americanbankingnews.comFY2025 EPS Estimate for Telix Pharmaceuticals Cut by AnalystAugust 31 at 2:21 AM | americanbankingnews.comTelix Pharmaceuticals (NASDAQ:TLX) Reaches New 12-Month Low - Here's What HappenedAugust 30 at 12:13 PM | marketbeat.comTelix Pharmaceuticals (NASDAQ:TLX) Earns "Outperform" Rating from WedbushAugust 30 at 9:33 AM | marketbeat.comWedbush Reiterates "Outperform" Rating for Telix Pharmaceuticals (NASDAQ:TLX)August 30 at 2:43 AM | americanbankingnews.comTelix Pharmaceuticals Limited (TLX) Hits Another Roadblock After SEC Subpoena, Shares Fall Again -- Hagens BermanAugust 29, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Telix Pharmaceuticals Limited – TLXAugust 29, 2025 | globenewswire.comHealth Check: Angry investors birch Telix shares after third US regulatory setbackAugust 29, 2025 | msn.comTelix Pharmaceuticals' (TLX) "Neutral" Rating Reaffirmed at JPMorgan Chase & Co.August 29, 2025 | americanbankingnews.comTelix shares just crashed 24%! Here's whyAugust 28, 2025 | msn.comAustralia's Telix Pharma says FDA seeks more data on cancer diagnostic drug; shares plungeAugust 28, 2025 | msn.comUS FDA seeks more information on Telix Pharma's diagnostic drug for kidney cancerAugust 27, 2025 | reuters.comTelix Pharmaceuticals (NASDAQ:TLX) Sees Unusually-High Trading Volume - What's Next?August 27, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Telix Pharmaceuticals Limited - TLXAugust 27, 2025 | prnewswire.comTelix Pharmaceuticals Limited (TLX) Shares Fall Amid SEC Subpoena -- Hagens BermanAugust 26, 2025 | globenewswire.comTelix to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference and H.C. Wainwright 27th Annual Global Investment ConferenceAugust 26, 2025 | globenewswire.comFY2027 EPS Estimate for Telix Pharmaceuticals Cut by AnalystAugust 26, 2025 | marketbeat.comWedbush Reduces Earnings Estimates for Telix PharmaceuticalsAugust 26, 2025 | americanbankingnews.comQ3 EPS Estimate for Telix Pharmaceuticals Reduced by AnalystAugust 26, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Telix Pharmaceuticals Limited – TLXAugust 25, 2025 | globenewswire.comTLX Investors Have Opportunity to Join Telix Pharmaceuticals Limited Fraud Investigation with the Schall Law FirmAugust 25, 2025 | prnewswire.comFY2028 Earnings Estimate for TLX Issued By WedbushAugust 24, 2025 | marketbeat.comTELIX ALERT: Bragar Eagel & Squire, P.C. is Investigating Telix Pharmaceuticals Limited on Behalf of Telix Stockholders and Encourages Investors to Contact the FirmAugust 23, 2025 | globenewswire.comWhat is Wedbush's Estimate for TLX FY2028 Earnings?August 23, 2025 | americanbankingnews.comTelix Pharmaceuticals (NASDAQ:TLX) Sets New 52-Week Low - What's Next?August 22, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Telix Pharmaceuticals Limited - TLXAugust 22, 2025 | prnewswire.comRosen Law Firm Encourages Telix Pharmaceuticals Ltd. Investors to Inquire About Securities Class Action Investigation – TLXAugust 21, 2025 | businesswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Telix Pharmaceuticals Limited – TLXAugust 21, 2025 | globenewswire.comTelix Pharmaceuticals (NASDAQ:TLX) Sees Large Volume Increase - Should You Buy?August 21, 2025 | marketbeat.comTelix Pharmaceuticals Limited Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – TLXAugust 21, 2025 | businesswire.comTLX Investors Have Opportunity to Join Telix Pharmaceuticals Limited Fraud Investigation with the Schall Law FirmAugust 21, 2025 | prnewswire.comTelix Pharmaceuticals Reports Strong Revenue Growth Amid Strategic InvestmentsAugust 21, 2025 | msn.comTelix Pharmaceuticals Reports Robust H1 2025 Results Amid Strategic Growth InvestmentsAugust 21, 2025 | msn.comTelix Pharmaceuticals Limited 2025 Q2 - Results - Earnings Call PresentationAugust 21, 2025 | seekingalpha.comTelix 2025 Half-Year Results: Strong commercial performance enables investment for long-term growthAugust 20, 2025 | globenewswire.comTelix Pharmaceuticals Limited (TLX) Shares Fall Amid SEC Subpoena -- Hagens BermanAugust 20, 2025 | globenewswire.comTelix Pharmaceuticals (NASDAQ:TLX) Stock Price Up 4.3% - Should You Buy?August 17, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Telix Pharmaceuticals Limited – TLXAugust 17, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Telix Pharmaceuticals Limited - TLXAugust 16, 2025 | prnewswire.comTelix Pharmaceuticals (NASDAQ:TLX) Sees Unusually-High Trading Volume - Here's What HappenedAugust 15, 2025 | marketbeat.comTelix Pharmaceuticals (TLX) Projected to Post Earnings on WednesdayAugust 14, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Telix Pharmaceuticals Limited – TLXAugust 13, 2025 | globenewswire.comTelix Pharmaceuticals Limited (TLX) Shares Fall Amid SEC Subpoena – Hagens BermanAugust 12, 2025 | globenewswire.comTelix Pharmaceuticals (NASDAQ:TLX) Reaches New 1-Year Low - Time to Sell?August 12, 2025 | marketbeat.com Get Telix Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TLX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TLX Media Mentions By Week TLX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TLX News Sentiment▼-0.221.13▲Average Medical News Sentiment TLX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TLX Articles This Week▼344▲TLX Articles Average Week Get the Latest News and Ratings for TLX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Telix Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies GMAB News VTRS News RDY News ASND News QGEN News MRNA News BBIO News ELAN News VRNA News ROIV News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TLX) was last updated on 9/2/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredWashington prepares for warWhile the headlines obsess over overseas conflicts, Washington has been quietly preparing for something much b...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telix Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Telix Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
